{
    "2018-11-06": [
        [
            {
                "time": "2023-10-15",
                "original_text": "医药三季报总结:医药大数据,成长依旧,估值近前低,正是战略布局好时机",
                "features": {
                    "keywords": [
                        "医药",
                        "三季报",
                        "大数据",
                        "成长",
                        "估值",
                        "战略布局"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}